secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2026-06-26T10:02:23+00:00
Accession:  0001651308-26-000020
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BeOne Medicines settles China tax audit; pays ~RMB 446M in Q2 2026
------------------------------------------------------------------

- Settled statutory tax audit in China; payment of approx. RMB 446 million (including surcharges and interest) to be recognized in Q2 2026.
- No administrative penalty imposed; adjustments to previously filed tax returns agreed with local tax authority.
- The payment resolves an uncertain tax position previously disclosed in the Q1 2026 10-Q filing.
- Approximate USD equivalent ~$62M based on current exchange rates; cash flow impact in 2Q 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130826000020/0001651308-26-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130826000020/bgne-20260626.htm
  HTML page:      https://secwatch.observer/filing/0001651308-26-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer